Cardiff Lexington Corporation (CDIX)
OTCMKTS: CDIX · Delayed Price · USD
7.50
0.00 (0.00%)
Jun 10, 2024, 10:20 AM EDT - Market closed
Company Description
Cardiff Lexington Corporation, together with its subsidiaries, operates in health care business in the United States.
The company Healthcare, and Real Estate segments. It also provides tax resolution service to individuals and companies that have federal and state tax liabilities; and a range of diagnostic and surgical services for injuries and disorders of the skeletal system and associated bones, joints, tendons, muscles, ligaments, and nerves.
In addition, the company engages in the commercial real estate property business. The company was formerly known as Cardiff International, Inc. and changed its name to Cardiff Lexington Corporation in January 2018.
Cardiff Lexington Corporation is based in Las Vegas, Nevada.
Cardiff Lexington Corporation
| Country | United States |
| Founded | 1986 |
| Industry | Asset Management |
| Sector | Financials |
| Employees | 13 |
| CEO | Alex H. Cunningham |
Contact Details
Address: 3753 Howard Hughes Parkway, Suite 200 Las Vegas, Nevada 89169 United States | |
| Phone | 844-628-2100 |
| Website | cardifflexington.com |
Stock Details
| Ticker Symbol | CDIX |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000811222 |
| CUSIP Number | 14146R403 |
| ISIN Number | US14146R4039 |
| Employer ID | 84-1044583 |
| SIC Code | 8011 |
Key Executives
| Name | Position |
|---|---|
| Alex H. Cunningham | Chief Executive Officer, President and Director |
| Daniel R. Thompson | Chairman of the Board and Secretary |
| Zia Choe C.P.A. | Chief Accounting Officer |
| Matthew T. Shafer | Senior Vice President, Chief Financial Officer and Treasurer |
| Dr. Kevin Fitzgerald M.D. | Managing Director of Nova Ortho and Spine |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 18, 2024 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Jun 17, 2024 | FWP | Free Writing Prospectus |
| Jun 12, 2024 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Jun 11, 2024 | 8-K | Current Report |
| Jun 10, 2024 | 8-K | Current Report |
| May 31, 2024 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| May 14, 2024 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| May 14, 2024 | 8-K | Current Report |
| May 10, 2024 | 10-Q | Quarterly Report |
| Apr 17, 2024 | DEF 14C | Filing |